EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Combination adjuvant improves influenza virus immunity by downregulation of immune homeostasis genes in lymphocytes

Emmanuel Dollinger iD, Jenny Hernandez-Davies, Jiin Felgner, Aarti Jain iD, Michael Hwang iD, Erwin Strahsburger iD, Rie Nakajima iD, Algimantas Jasinskas, Qing Nie, Egest James Pone, Shivashankar Othy, David Huw Davies iD

ImmunoHorizons · 2025

DOI: 10.1093/immhor/vlae007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ImmunoHorizons, 2025. Verfasst von Emmanuel Dollinger und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mathematics, University of California Irvine, Irvine, CA, United States. Hauptthemen laut MEDLINE: Adjuvants, Immunologic, Influenza Vaccines, Influenza A Virus, H5N1 Subtype, Orthomyxoviridae Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of California, Irvine, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adjuvants play a central role in enhancing the immunogenicity of otherwise poorly immunogenic vaccine antigens. Combining adjuvants has the potential to enhance vaccine immunogenicity compared with single adjuvants, although the cellular and molecular mechanisms of combination adjuvants are not well understood. Using the influenza virus hemagglutinin H5 antigen, we define the immunological landscape of combining CpG and MPLA (TLR-9 and TLR-4 agonists, respectively) with a squalene nanoemulsion (AddaVax) using immunologic and transcriptomic profiling. Mice immunized and boosted with recombinant H5 in AddaVax, CpG+MPLA, or AddaVax plus CpG+MPLA (IVAX-1) produced comparable levels of neutralizing antibodies and were equally well protected against the H5N1 challenge. However, after challenge with H5N1 virus, H5/IVAX-1–immunized mice had 100- to 300-fold lower virus lung titers than mice receiving H5 in AddaVax or CpG+MPLA separately. Consistent with enhanced viral clearance, unsupervised expression analysis of draining lymph node cells revealed the combination adjuvant IVAX-1 significantly downregulated immune homeostasis genes, and induced higher numbers of antibody-producing plasmablasts than either AddaVax or CpG+MPLA. IVAX-1 was also more effective after single-dose administration than either AddaVax or CpG+MPLA. These data reveal a novel molecular framework for understanding the mechanisms of combination adjuvants, such as IVAX-1, and highlight their potential for the development of more effective vaccines against respiratory viruses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adjuvants, ImmunologicInfluenza VaccinesInfluenza A Virus, H5N1 SubtypeOrthomyxoviridae InfectionsLymphocytesAnimalsMiceSqualeneFemaleAntibodies, ViralHomeostasisDown-RegulationAntibodies, NeutralizingMice, Inbred BALB CHemagglutinin Glycoproteins, Influenza VirusSaponinsOligodeoxyribonucleotidesLipid APolysorbates

Stichwörter der Autor:innen

combination adjuvantinfluenzalymphocytessingle-cell transcriptomicssynergy

Substanzen

Adjuvants, ImmunologicInfluenza VaccinesSqualeneAntibodies, ViralAddavaxAntibodies, NeutralizingHemagglutinin Glycoproteins, Influenza VirusSaponinsOligodeoxyribonucleotidesLipid A

Autor:innen und Institutionen

  • Department of Mathematics, University of California Irvine, Irvine, CA, United States.
  • Vaccine Research & Development Center, Department of Physiology & Biophysics, University of California Irvine, Irvine, CA 92697, United States.

ORCID-Profile: Emmanuel Dollinger, Aarti Jain, Michael Hwang, Erwin Strahsburger, Rie Nakajima, David Huw Davies

Förderung

  • University of California, Irvine
  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Molecular Mechanisms of Combination Adjuvants
  • Simons Foundation
  • Genomics Research and Technology Hub
  • Defense Threat Reduction Agency
  • NIH HHS

Zitieren

APA

Dollinger, E., Hernandez-Davies, J., Felgner, J., Jain, A., Hwang, M., Strahsburger, E., Nakajima, R., Jasinskas, A., Nie, Q., Pone, E. J., Othy, S., & Davies, D. H. (2025). Combination adjuvant improves influenza virus immunity by downregulation of immune homeostasis genes in lymphocytes. ImmunoHorizons. https://doi.org/10.1093/immhor/vlae007

Vancouver

Dollinger E, Hernandez-Davies J, Felgner J, Jain A, Hwang M, Strahsburger E, et al. Combination adjuvant improves influenza virus immunity by downregulation of immune homeostasis genes in lymphocytes. ImmunoHorizons. 2025. doi:10.1093/immhor/vlae007

BibTeX
@article{Dollinger2025,
  author = {Dollinger, Emmanuel and Hernandez-Davies, Jenny and Felgner, Jiin and Jain, Aarti and Hwang, Michael and Strahsburger, Erwin and Nakajima, Rie and Jasinskas, Algimantas and Nie, Qing and Pone, Egest James and Othy, Shivashankar and Davies, David Huw},
  title = {Combination adjuvant improves influenza virus immunity by downregulation of immune homeostasis genes in lymphocytes},
  journal = {ImmunoHorizons},
  year = {2025},
  doi = {10.1093/immhor/vlae007}
}
Kostenlos starten →